InvestorsHub Logo

subslover

09/27/22 7:42 PM

#53869 RE: JMC$ #53670

JMC$ do you like this line from the filing? Let me know your thoughts.

In addition, the Company has filed data with the FDA, as part of IND #17448, which demonstrated that treatment of cancer patients with StemVacs™ resulted in enhanced activity of a type of immunological cell called “natural killer” cells, otherwise known as “NK cells.”